1. Academic Validation
  2. Cyramza (Ramucirumab) Approved for the Treatment of Advanced Gastric Cancer and Metastatic Non-Small-Cell Lung Cancer

Cyramza (Ramucirumab) Approved for the Treatment of Advanced Gastric Cancer and Metastatic Non-Small-Cell Lung Cancer

  • Am Health Drug Benefits. 2015 Mar;8(Spec Feature):49-53.
Loretta Fala
PMID: 26629266
Figures
Products